What does Senticell do?
Senticell develops liquid-biopsy diagnostics based on red-cell-bound nucleic acids, using technology licensed exclusively from the University of Pennsylvania. Its platform aims to detect disease across oncology, infection, and autoimmune conditions from molecular signals bound to red blood cells. The company is based in Princeton, New Jersey.